Back
Emergent BioSolutions Stock Price Chart
Sponsored
EBS
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
EBS
Emergent BioSolutions
Last Price:
$8.04
Seasonality Move:
1.23%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EBS is experiencing slight buying pressure.
Emergent BioSolutions Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.47 | Sell |
20-day SMA: | 9.07 | Sell |
50-day SMA: | 9.26 | Sell |
200-day SMA: | 7.1 | Buy |
8-day EMA: | 8.44 | Sell |
20-day EMA: | 8.82 | Sell |
50-day EMA: | 8.99 | Sell |
200-day EMA: | 7.75 | Buy |
Emergent BioSolutions Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.31 | Sell |
Relative Strength Index (14 RSI): | 39.3 | Sell |
Chaikin Money Flow: | 571253 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.3 - 9.64) | Sell |
Bollinger Bands (100): | (7.5 - 10.12) | Sell |
Emergent BioSolutions Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Emergent BioSolutions Stock
Is Emergent BioSolutions Stock a Buy?
-
Emergent BioSolutions share price is 8.10 while EBS 8-day simple moving average is 8.47, which is a Sell signal.
-
The stock price of EBS is 8.10 while Emergent BioSolutions 20-day SMA is 9.07, which makes it a Sell.
-
Emergent BioSolutions 50-day simple moving average is 9.26 while EBS share price is 8.10, making it a Sell technically.
-
EBS stock price is 8.10 and Emergent BioSolutions 200-day simple moving average is 7.10, creating a Buy signal.
EBS Technical Analysis vs Fundamental Analysis
Sell
27
Emergent BioSolutions (EBS)
is a Sell
Is Emergent BioSolutions a Buy or a Sell?
-
Emergent BioSolutions stock is rated a SellThe current Emergent BioSolutions [EBS] share price is $8.10. The Score for EBS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Emergent BioSolutions Stock Info
Market Cap:
438.9M
Price in USD:
8.10
Share Volume:
2.5M
Emergent BioSolutions 52-Week Range
52-Week High:
15.10
52-Week Low:
1.42
Sell
27
Emergent BioSolutions (EBS)
is a Sell
Emergent BioSolutions Share Price Forecast
-
What is the Emergent BioSolutions stock price today?The Emergent BioSolutions stock price is 8.10 USD today.
-
Will EBS stock go up or go down?Emergent BioSolutions> share price is forecast to RISE/FALL based on technical indicators
-
Is Emergent BioSolutions overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Emergent BioSolutions is overvalued.
Is Emergent BioSolutions Stock a Buy?
-
Emergent BioSolutions share price is 8.10 while EBS 8-day exponential moving average is 8.44, which is a Sell signal.
-
The stock price of EBS is 8.10 while Emergent BioSolutions 20-day EMA is 8.82, which makes it a Sell.
-
Emergent BioSolutions 50-day exponential moving average is 8.99 while EBS share price is 8.10, making it a Sell technically.
-
EBS stock price is 8.10 and Emergent BioSolutions 200-day simple moving average is 7.75, creating a Buy signal.
Fundamental Analysis of Emergent BioSolutions
Is Emergent BioSolutions a good investment?
-
Analysts estimate an earnings increase this quarter of $1.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.87 per share, and an increase next year of $3.99 per share.
Technical Analysis of Emergent BioSolutions
Should I short Emergent BioSolutions stock?
-
EBS Moving Average Covergence Divergence (MACD) indicator is -0.31, suggesting Emergent BioSolutions is a Sell
-
Emergent BioSolutions Relative Strength Index (RSI) is 39.3, which suggest Emergent BioSolutions is oversold
-
The Bollinger Bands (25) for Emergent BioSolutions is (8.3 - 9.64), which suggest Emergent BioSolutions is a Sell
-
The Bollinger Bands (100) for Emergent BioSolutions is (7.5 - 10.12), which suggest Emergent BioSolutions is a Sell
* Emergent BioSolutions stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.